(Q45927203)

17 December 2017

title

Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study. (English)

1 reference

17 December 2017

central retinal vein occlusion

main subject

1 reference

Alexander Rouvas

1

1 reference

17 December 2017

Petros Petrou

2

1 reference

17 December 2017

Ioannis Vergados

3

1 reference

17 December 2017

Dimitrios Pechtasides

4

1 reference

17 December 2017

Vasilios Liarakos

5

1 reference

17 December 2017

Maria Mitsopoulou

6

1 reference

17 December 2017

Ioannis Ladas

7

1 reference

17 December 2017

publication date

16 July 2009

1 reference

17 December 2017

Graefe's Archive for Clinical and Experimental Ophthalmology

published in

1 reference

17 December 2017

volume

247

1 reference

17 December 2017

issue

12

1 reference

17 December 2017

page(s)

1609-1616

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/s00417-009-1138-y

exact match

0 references

cites work

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

12 December 2020

Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator.

1 reference

12 December 2020

Intravitreal bevacizumab (avastin) in central retinal vein occlusion

1 reference

12 December 2020

Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions

1 reference

12 December 2020

Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.

1 reference

12 December 2020

Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report

1 reference

12 December 2020

Optical coherence tomographic patterns of diabetic macular edema.

1 reference

12 December 2020

Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion

1 reference

12 December 2020

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

12 December 2020

Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.

1 reference

12 December 2020

Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases

1 reference

12 December 2020

Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion.

1 reference

12 December 2020

Bevacizumab in retinal vein occlusion-results of a prospective case series

1 reference

12 December 2020

[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]

1 reference

12 December 2020

Baseline and early natural history report. The Central Vein Occlusion Study

1 reference

12 December 2020

Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study

1 reference

12 December 2020

Vascular permeability factor, an endothelial cell mitogen related to PDGF

1 reference

12 December 2020

A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report

1 reference

12 December 2020

Ranibizumab for neovascular age-related macular degeneration

1 reference

12 December 2020

Early bevacizumab treatment of central retinal vein occlusion

1 reference

12 December 2020

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

12 December 2020

Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial

1 reference

12 December 2020

Intraocular triamcinolone acetonide for macular edema due to CRVO. A multifocal-ERG and OCT study

1 reference

12 December 2020

Vascular endothelial growth factor is a critical stimulus for diabetic macular edema

1 reference

12 December 2020

Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial

1 reference

12 December 2020

Analysis of macular thickness in British population using optical coherence tomography (OCT): an emphasis on interocular symmetry

1 reference

12 December 2020

Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes

1 reference

12 December 2020

One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion

1 reference

12 December 2020

Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion

1 reference

12 December 2020

10.1007/S00417-009-1138-Y

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017